PubRank
Search
About
Anna Lutyńska
Author PubWeight™ 3.65
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
MBio
2014
1.76
2
Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
Infect Genet Evol
2011
1.01
3
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.
J Clin Microbiol
2011
0.82
4
Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland.
Arch Immunol Ther Exp (Warsz)
2014
0.75
5
Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment.
Przegl Epidemiol
2013
0.75
6
[Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products].
Med Dosw Mikrobiol
2013
0.75
7
The rate of adverse events following BCG vaccination in Poland.
Przegl Epidemiol
2012
0.75
8
PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases.
Pol J Microbiol
2014
0.75
9
[Susceptibility of Lactobacillus rhamnosus strains isolated from probiotic products to antimicrobial agents].
Med Dosw Mikrobiol
2015
0.75
10
The capacity of Mycobacterium tuberculosis complex species and M. bovis BCG substrains specific identification - implications for optimized PCR-based diagnostics in adverse events following vaccination suspected cases.
Pol J Microbiol
2012
0.75
11
[The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection].
Med Dosw Mikrobiol
2013
0.75
12
Erratum: Global phylogeography and evolutionary history of Shigella dysenteriae type 1.
Nat Microbiol
2016
0.75
13
Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants.
Biologicals
2013
0.75
14
[Detection of the adventitious agents in the evaluation of vaccine safety].
Przegl Epidemiol
2012
0.75
15
[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].
Przegl Epidemiol
2012
0.75
16
Effectiveness of experimental whole-cell pertussis vaccines in murine model.
Med Dosw Mikrobiol
2014
0.75
17
Descendant of daughter Brazilian BCG Moreau substrain in Poland.
Vaccine
2012
0.75
18
[Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines].
Med Dosw Mikrobiol
2014
0.75
19
Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
Vaccine
2011
0.75